Trupanion: Recovery Is Real, and the Story Is Narrower Now
Margins are healing, subscription economics remain solid, and the bet is getting simpler. By Benjamin Tan
Trupanion’s (TRUP 0.00%↑) latest quarter (Q1 2026) did not change the story so much as clarify it. This is no longer the old hypergrowth pet insurance darling that could do no wrong. It is a more mature, more disciplined business rebuilding credibility through better pricing, stronger margins, and steadier execution. That is a less glamorous story, but a more investable one.
Q1 2026 Numbers: Summary
The headline numbers were solid. Q1 2026 revenue rose 12% to $384m, while subscription revenue grew 16% to $269.5m. Net income came in at $4.9m versus a loss a year ago, and adjusted EBITDA improved to $17.4m from $12.2m. Cash and short-term investments ended the quarter at $383.7m against total debt of about $109m, so balance sheet risk remains low.
The real signal, though, is inside the subscription business. Subscription adjusted operating income rose 28% to $38.4m, and subscription adjusted operating margin reached 14.2%, up from 12.9% a year ago and the highest Q1 margin in company history. The subscription cost of paying veterinary invoices improved to 70.8% of subscription revenue from 71.8%, while fixed expenses fell to 5.8% of revenue from 6.2%. In plain English, pricing is catching up, and the operating model is scaling again.
Healthy Growth and Reacceleration of Core Business
Growth is not pristine, but it is healthy where it matters. Subscription pets increased 5% year over year to 1.106m, average monthly revenue per pet rose 11% to $85.79, and retention improved slightly to 98.35%. Pet acquisition cost rose to $315 from $267, so growth is not free, but management is still investing from a position of strength, not desperation.
The weak spot remains the non-core business. Total enrolled pets actually declined 2% year over year, and management expects growth in the other business segment to continue decelerating as it stops enrolling new pets in most U.S. states for its largest partner. That reinforces the right lens for analyzing TRUP 0.00%↑: focus on the subscription business and treat the rest as runoff.
Takeaway: Staying Invested and Interested
My takeaway is straightforward. The core business looks intact. Margins are improving. Growth is slower than it was in the glory days, but not broken. At this point, the thesis is no longer about dreaming on optionality. It is about underwriting a niche insurer that can still grow subscription revenue around the mid-teens while keeping pricing disciplined and returns attractive. That is enough for me to stay interested via a small stake that was further increased in Q1 2026 in my Traditional IRA.
My book, Suit Yourself: A Portfolio Strategy for Every Personality Type, blends Enneagram psychology, pop culture, and behavioral finance to offer a personalized roadmap to investing. It examines how personality biases unconsciously influence investing behaviors. Learn more at my author page or order the book on Amazon. Follow me on X.com (formerly Twitter) @ConsumeOwnTech and Yahoo Finance.
Subscribe to Consume Your Own Tech Investing FOR FREE to receive a welcome email with the following:
My Top 10 high-conviction portfolio positions, combining value and growth stocks
Book recommendations in investing, consumer, and tech sectors
Monthly articles delivered straight to your inbox